ZNTL insider receives 9,727 shares in stock awards
By AlphaYouPublished Form 4
Bruns Ingmar
Reporting filer
Bruns Ingmar reported 9,727 shares of Common Stock in Zentalis Pharmaceuticals, Inc. as grants or awards dated 2026-09-30. The Form 4 was disclosed on Oct 1, 2026. These were stock awards, not open-market purchases.
- Disclosed
- Oct 1, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Bruns Ingmar | 2026-09-30 | A | Grant or award | 9727 | 2.18 | 43,059 | 1 day | Filed terms
|
Common Stock
- Owner
- Bruns Ingmar
- Date
- 2026-09-30
- Code
- A
- Action
- Grant or award
- Quantity
- 9727
- Price
- 2.18
- Following holdings
- 43,059
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-30
- transaction Form Type: 5
- transaction Code: A
- equity Swap Involved: 0
- id: F1
- transaction Timeliness: E
- transaction Shares: 9727
- transaction Price Per Share: 2.18
- id: F2
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 43059
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Bruns Ingmar: Chief Medical Officer.
- F1: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2020 Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of April 1, 2026 through September 30, 2026. This transaction is exempt under Rule 16b-3(c).
- F2: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on April 1, 2026.
Original sources
Prepared automatically from public filing data. Report a correction.